Fresenius SE Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis

Date: May 15, 2018
Pages: 50
US$ 499.00
Fresenius SE Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: F6B0EE33034BEN

Download PDF Leaflet

Fresenius SE Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis
Fresenius SE Due Diligence Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Fresenius SE and its competitors. This provides our Clients with a clear understanding of Fresenius SE position in the Healthcare Industry.

  • The report contains detailed information about Fresenius SE that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Fresenius SE. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Fresenius SE financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Fresenius SE competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Fresenius SE business.

About Fresenius SE

Fresenius AG, a global health care company, provides products and services for dialysis, hospital, and medical care of patients at home. In addition, the company focuses on hospital management, as well as on engineering and services for hospitals and the pharmaceutical industry. The company operates in three segments: Fresenius Medical Care, Fresenius Kabi, and Fresenius ProServe.

Fresenius Medical Care

Fresenius Medical Care AG serves as an integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure. Through its network of approximately 1,630 dialysis clinics in North America, Europe, Latin America and Asia-Pacific, Fresenius Medical Care provides Dialysis Treatment to approximately 125,900 patients around the globe. Fresenius Medical Care also provides Dialysis Products, such as hemodialysis machines, dialyzers and related disposable products. On May 4, 2005, Fresenius Medical Care AG announced that it has entered into an agreement to acquire Renal Care Group, Inc., a dialysis service provider.

The DiaSafe filter, the On-line Clearance Monitor, which is used to monitor the vascular access and the Twister also developed. DiaSafe is used to produce ultrapure dialysis fluid during hemodialysis and minimizes the risk of infection through dialysis. Twister offers blood flow monitoring during treatment.

Haemodialysis: The company offers machines for haemodialysis, haemodiafiltration, haemofiltration, acute dialysis, plasmafiltration; Low-Flux dialysers (Fresenius Polysulfon); High-Flux dialysers (Fresenius Polysulfon); FX-class dialysers (Helixone); Haemofilters for acute and chronic renal replacement therapy; Plasmafilters; Dialysis fluid filters; Tubing systems; Dialysis cannulae; Dialysis fluids; Dialysis concentrates (liquid, dry); Haemofiltration solutions; Irrigation solutions; Disinfectants; Water treatment systems; Analysis devices; and Data management systems.

Peritoneal dialysis: The company offers machines and tubing systems for Automated Peritoneal Dialysis (APD); Peritoneal dialysis solutions; CAPD systems; CAPD double chamber systems; Peritoneal dialysis catheters; and Accessories.

Dialysis care: The company offers Dialysis clinics for chronic haemodialysis treatment; Acute in-patient dialysis treatment; and Training (haemodialysis and peritoneal dialysis).

Spectra Renal Management: The company offers Laboratory and diagnostic dialysis-related services; Data management; and Managed care services for dialysis patients.

Adsober technology: The company offers LDL apheresis: DALI system; and Immunoadsorption: Prosorba system and Immunosorba system.

Fresenius Kabi

Fresenius Kabi engages in Infusion Therapy and Clinical Nutrition in Europe and in its major countries of Latin America and Asia Pacific. Fresenius Kabi’s core product range includes infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs, as well as parenteral and enteral nutrition. Furthermore, the company offers medical devices for the application of Infusion Therapy and Clinical Nutrition and Infusion Management. In addition, Fresenius Kabi is active in the field of Transfusion Technology, supplying blood processing systems, as well as blood bags and filters.

Fresenius Kabi’s portfolio comprises three business units that include:

Infusion therapy: Products for fluid and blood-volume replacement, as well as intravenously administered drugs, such as anesthetics for general anesthesia, as well as medical devices for the administration of infusion therapies and for infusion management.

The company offers basic solutions; solutions for osmotic therapy; irrigation solutions/urology; infusion solutions for blood volume replacement and haemodilution therapy; I.V. anaesthetics; I.V. anti-infective drugs and disinfectants; I.V. catecholamines; and I.V. packaging systems.

Clinical Nutrition: Parenteral (intravenous) and enteral (via sip and tube feeds) nutrition for patients who are unable to not allowed to eat any or sufficient normal food, as well as medical devices for the administration of nutrition therapies.

The co

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.




1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History


2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units


3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats


4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot


5.1. Fresenius SE Direct Competitors
5.2. Comparison of Fresenius SE and Direct Competitors Financial Ratios
5.3. Comparison of Fresenius SE and Direct Competitors Stock Charts
5.4. Fresenius SE Industry Analysis
  5.4.1. Healthcare Services Industry Snapshot
  5.4.2. Fresenius SE Industry Position Analysis


6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events


7.1. Experts Opinion
7.2. Experts Estimates



9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors


10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix





Fresenius SE Key Facts
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Fresenius SE Key Executives
Key Executives Biographies1
Key Executives Compensations1
Fresenius SE Major Shareholders
Fresenius SE History
Fresenius SE Products
Revenues by Segment
Revenues by Region
Fresenius SE Offices and Representations
Fresenius SE SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Fresenius SE Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Fresenius SE Capital Market Snapshot
Fresenius SE Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Services Industry Statistics
Fresenius SE Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Fresenius SE Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1


Fresenius SE Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Fresenius SE 1-year Stock Charts
Fresenius SE 5-year Stock Charts
Fresenius SE vs. Main Indexes 1-year Stock Chart
Fresenius SE vs. Direct Competitors 1-year Stock Charts
Fresenius SE Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

SWOT Analysis

SWOT, which stands for Strengths, Weaknesses, Opportunities and Threats, is an analytical framework that identifies the internal and external factors that are favorable and unfavorable for a company.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to imitate?
  • Organized properly?
Skip to top

Fresenius business profile (company report) US$ 99.00 Aug, 2011 · 30 pages

Ask Your Question

Fresenius SE Due Diligence Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: